Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Journal of Neuroscience Research|March 20, 2003
Adenoviral gene transfer of GDNF, BDNF and TGF beta 2, but not CNTF, cardiotrophin-1 or IGF1, protects injured adult motoneurons after facial nerve avulsionTsuyoshi Sakamoto, Yoko Kawazoe, Jin-Song Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissuesTakashi Yokoo, Toya Ohashi, Jin Song Shen, et al.
Molecular Genetics and Metabolism|November 6, 2010
Pathology of the first autopsy case diagnosed as mucolipidosis type III α/β suggesting autophagic dysfunctionHiroshi Kobayashi, Junko Takahashi-Fujigasaki, Takahiro Fukuda, et al.
Molecular Genetics and Metabolism|October 9, 2013
Enzyme augmentation therapy enhances the therapeutic efficacy of bone marrow transplantation in mucopolysaccharidosis type II miceKazumasa Akiyama, Yohta Shimada, Takashi Higuchi, et al.
Journal of Cardiology|October 19, 2019
Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patientsAyumi Nojiri, Ikuko Anan, Satoshi Morimoto, et al.
Molecular Genetics and Metabolism|June 19, 2012
Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS IITakashi Higuchi, Hiromi Shimizu, Takahiro Fukuda, et al.
Plos One|June 18, 2015
Rapid Immunochromatographic Detection of Serum Anti-α-Galactosidase A Antibodies in Fabry Patients after Enzyme Replacement TherapySachie Nakano, Takahiro Tsukimura, Tadayasu Togawa, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2020
Ex Vivo Gene Therapy Treats Bone Complications of Mucopolysaccharidosis Type II Mouse Models through Bone Remodeling ReactivationMiho Wada, Yohta Shimada, Sayoko Iizuka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 4, 2024
Role of Longitudinal Strain in the Evaluation of Contractile Dysfunction in Japanese Fabry Disease PatientsAyumi Nojiri, Satoshi Morimoto, Eiko Fukuro, et al.
Molecular Genetics and Metabolism Reports|July 5, 2022
The role of native T1 values on the evaluation of cardiac manifestation in Japanese Fabry disease patientsIkuko Anan, Toru Sakuma, Eiko Fukuro, et al.
Pageof 14